Perfusion MR Imaging with a Superparamagnetic Iron Oxide Using T2-weighted and Susceptibility-sensitive Echoplanar Sequences: Evaluation of Tumor Vascularity in Hepatocellular Carcinoma
Overview
Affiliations
Objective: The study purpose was to examine the usefulness of perfusion echoplanar MR imaging with a superparamagnetic iron oxide (SHU-555A) for evaluating the vascularity of hepatocellular carcinomas.
Subjects And Methods: Twenty-two patients with 32 hepatocellular carcinomas underwent perfusion imaging with bolus injection (0.7-1.1 ml) of SHU-555A. Echoplanar sequences included multishot spin-echo (17 patients) and single-shot gradient-echo (five patients) imaging. Image acquisition was repeated every 30 sec for 3 min with the multishot spin-echo sequence and every 2 sec for 100 sec with the single-shot gradient-echo sequence. Lesion signal intensity versus time curves were created for quantitative analysis.
Results: Transient decreases in tumor signal intensity (28.8% with multishot spin-echo and 63.3% with the single-shot gradient-echo) were seen in the perfusion phase. These decreases in signal intensity were statistically significantly (p < .01) different for each histologic type of hepatocellular carcinoma (poorly differentiated, 43.3%; well differentiated, 18.4%; and moderately differentiated, 24.8%). After the perfusion phase, the tumor signal intensities rapidly recovered. The multishot spin-echo sequence could detect some signal changes even in lesions smaller than 1 cm.
Conclusion: Hepatocellular carcinoma vascularity can be evaluated with perfusion echoplanar imaging with SHU-555A. Because of its excellent temporal resolution, the single-shot gradient-echo echoplanar sequence detects the transient signal decrease in most lesions. The high image quality of the multishot spin-echo echoplanar sequence allows evaluation of the vascularity of even very small lesions.
Saito K, Ledsam J, Sourbron S, Araki Y Quant Imaging Med Surg. 2020; 10(6):1298-1306.
PMID: 32550138 PMC: 7276367. DOI: 10.21037/qims-18-233.
Shirota N, Saito K, Sugimoto K, Takara K, Moriyasu F, Tokuuye K Cancer Imaging. 2016; 16:1.
PMID: 26822946 PMC: 4731920. DOI: 10.1186/s40644-016-0059-3.
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Wang Y Quant Imaging Med Surg. 2012; 1(1):35-40.
PMID: 23256052 PMC: 3496483. DOI: 10.3978/j.issn.2223-4292.2011.08.03.
Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging.
Kiessling F, Jugold M, Woenne E, Brix G Eur Radiol. 2007; 17(8):2136-48.
PMID: 17308924 DOI: 10.1007/s00330-006-0566-x.
Zhao J, Feng G, Kong X, Li X, Li M, Cheng Y World J Gastroenterol. 2004; 10(8):1152-6.
PMID: 15069716 PMC: 4656351. DOI: 10.3748/wjg.v10.i8.1152.